A ONE-YEAR EVALUATION OF CALCIUM-CHANNEL BLOCKER OVERDOSES - TOXICITY AND TREATMENT

被引:105
|
作者
RAMOSKA, EA
SPILLER, HA
WINTER, M
BORYS, D
机构
[1] Division of Emergency Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
[2] Delaware Valley Regional Poison Control Center, Philadelphia, PA
[3] Texas State Poison Center, Galveston
[4] Hennepin Regional Poison Center, Minneapolis, MN
关键词
CALCIUM CHANNEL BLOCKER;
D O I
10.1016/S0196-0644(05)80202-1
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To examine the cardiovascular toxicity of calcium channel blockers and the efficacy of various treatments. Design: Case series collected prospectively over one year. Setting: Three regional poison control centers. Type of participants: One hundred thirty-nine hospitalized patients who had ingested a calcium channel blocker. Interventions: Calcium, dopamine, atropine, isoproterenol, glucagon, and pacemakers. Main results: Hypotension, sinus node suppression, and dysrhythmias often occur with calcium channel blocker overdoses, but atrioventricular nodal block occurs more often with verapamil (chi2 test, P<.025). Calcium was administered to 23 patients and was efficacious in reversing depression of cardiac conduction and increasing blood pressure. Dopamine was administered to ten patients and was efficacious in increasing blood pressure. Atropine was administered to eight patients, but only two had a positive response. Conclusion: Atrioventricular nodal depression is more common with verapamil overdoses. Calcium and dopamine are useful in treating toxicity from calcium channel blocker overdose, whereas atropine is sometimes useful.
引用
收藏
页码:196 / 200
页数:5
相关论文
共 50 条
  • [31] GYNECOMASTIA ASSOCIATED WITH CALCIUM-CHANNEL BLOCKER THERAPY
    TANNER, LA
    BOSCO, LA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (02) : 379 - 380
  • [32] BINDING OF BEPRIDIL, A CALCIUM-CHANNEL BLOCKER, TO CALMODULIN
    ITOH, H
    ISHIKAWA, T
    HIDAKA, H
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1985, 49 (08): : 900 - 900
  • [33] ANTIMETASTATIC EFFECT OF THE CALCIUM-CHANNEL BLOCKER DILTIAZEM
    ONODA, JM
    DIGLIO, C
    TAYLOR, JD
    HONN, KV
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 351 - 351
  • [34] CALCIUM-CHANNEL BLOCKER DRUGS AND DIABETIC CONTROL
    COLLINS, WCJ
    CULLEN, MJ
    FEELY, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (04) : 420 - 423
  • [35] IS THERE A BETTER CALCIUM-CHANNEL BLOCKER FOR HYPERTENSION - A METAANALYSIS
    MUTGI, AB
    AKPUNONU, BE
    FEDERMAN, DJ
    [J]. CLINICAL RESEARCH, 1993, 41 (02): : A545 - A545
  • [36] ILEXONIN A AS A CALCIUM-CHANNEL BLOCKER ON HUMAN PLATELET
    WANG, Z
    WANG, L
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (02) : 346 - 347
  • [37] AMIODARONE - A USE DEPENDENT CALCIUM-CHANNEL BLOCKER
    DEROODE, MR
    TALAJIC, M
    QUANTZ, M
    NATTEL, S
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : B63 - B63
  • [38] THE CALCIUM-CHANNEL BLOCKER SCARE - LESSONS FOR THE FUTURE
    LENFANT, C
    [J]. CIRCULATION, 1995, 91 (12) : 2855 - 2856
  • [39] METABOLIC EFFECTS OF CALCIUM-CHANNEL BLOCKER THERAPY
    COLLINS, WCJ
    CULLEN, MJ
    FEELY, J
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 1986, 155 (09) : 332 - 332
  • [40] THE EFFECT OF A CALCIUM-CHANNEL BLOCKER ON BONE MINERALIZATION
    CHARNOV, JH
    KAHN, EK
    CAIOZZO, VJ
    [J]. CLINICAL RESEARCH, 1988, 36 (01): : A150 - A150